| July, 2026 | Desk: Brand & IP Law | 19 min read · 4415 words |
Pakistan’s healthcare sector is undergoing a transformation that is creating new and complex brand protection challenges. Private hospitals, diagnostic laboratory chains, pharmacy networks, telemedicine platforms, specialist clinic brands, and healthcare technology companies are building commercially significant brand identities that rival those of consumer goods companies in terms of the trust, recognition, and economic value they represent.
Aga Khan Hospital, Shaukat Khanum Memorial Cancer Hospital, Fatima Memorial Hospital, and Liaquat National Hospital are among the most trusted brand names in Pakistan. These institutions have built their brand equity over decades. But the commercial healthcare landscape now extends well beyond these established names. Branded diagnostic chains like Chughtai Lab and Essa Lab have built national footprints. Pharmacy chains have moved to branded retail models. Telemedicine platforms have created new brand categories. Specialist clinic franchises in dermatology, dentistry, orthopaedics, and ophthalmology are expanding nationally under consolidated brand names.
This expansion in branded healthcare has arrived without a corresponding expansion in intellectual property awareness among healthcare providers. Many Pakistani healthcare brands are operating at significant commercial scale without trademark registration, without documented licensing arrangements for their franchise clinic models, and without systems for monitoring or enforcing against imitators and impersonators. The commercial and patient safety consequences of this protection gap are more serious in healthcare than in almost any other sector.
Nice Classes for Healthcare Brands
| Class | What it covers in healthcare | File when |
| Class 44 | Medical & veterinary services, hospitals, clinics, diagnostic labs, physiotherapy, dental care, telemedicine, online medical consultations | Always — the foundational class for all healthcare service brands |
| Class 5 | Pharmaceuticals, health supplements, medical preparations, disinfectants, dietary supplements, baby food, medicines | Always for pharmacy chains and pharmaceutical retailers; also for hospitals and clinics selling health products |
| Class 9 | Mobile health apps, telemedicine software, electronic health records, diagnostic software, wearable health devices | Always for telemedicine and digital health brands; also hospitals with patient-facing apps |
| Class 10 | Surgical instruments, medical devices, prosthetics, hearing aids, diagnostic equipment, medical imaging equipment | Medical device brands, equipment manufacturers, healthcare technology companies |
| Class 35 | Hospital management services, healthcare consulting, medical billing, business administration for health entities | B2B healthcare services, hospital management companies, healthcare consultancies |
| Class 41 | Medical education, training, CPD programmes, patient education, accredited clinical training | Teaching hospitals, medical training institutions, professional development providers |
Why Healthcare Brand Protection Is Different
| ⚠ Patient safety: the dimension that changes everything |
| In most sectors, a consumer who is confused by an imitation brand loses money or receives a substandard product. In healthcare, a patient who is confused by a clinical impersonator, a fake diagnostic laboratory, or a counterfeit pharmaceutical can lose their health or their life. A fake diagnostic laboratory impersonating Chughtai Lab can issue fabricated test results that lead to incorrect medical decisions. A counterfeit pharmacy can dispense substandard or falsified medicines. An impersonation clinic operating under the name of a reputable specialist practice can provide harmful clinical care to patients who believe they are receiving care from qualified practitioners. These are not commercial harms. They are potential medical emergencies. The patient safety dimension makes healthcare brand protection categorically different from brand protection in any other sector. |
Regulatory Complexity
Healthcare businesses in Pakistan operate under regulatory frameworks administered by multiple bodies: the Pakistan Medical Commission regulates medical professionals and institutions, the Drug Regulatory Authority of Pakistan regulates pharmaceuticals and medical devices, provincial healthcare regulatory authorities regulate healthcare facilities, and various professional councils regulate specific healthcare disciplines. These regulatory frameworks create naming requirements, disclosure obligations, and professional standards that intersect with trademark law in ways that do not exist in most other sectors.
Reputation Asymmetry
A healthcare brand’s reputation takes years to build through consistent clinical outcomes, patient experience, professional staffing, and community trust. It can be destroyed in days by a single well-publicised failure, whether genuine or fabricated by an impersonator. The commercial damage from a healthcare brand being associated with a single bad clinical outcome at an impersonation facility is not recoverable by the same mechanisms available to, say, a food brand dealing with a product quality issue. Healthcare brand reputations are extraordinarily fragile and extraordinarily valuable simultaneously.
The Regulatory Dimension: PMC, DRAP, and Trademark Registration
When a fintech company obtains a payment licence from the State Bank of Pakistan, it does not acquire trademark rights. The same principle applies throughout healthcare: regulatory registration does not equal trademark protection.
The Pakistan Medical Commission regulates hospitals and medical institutions. Facility licensing and professional registration requirements mean that healthcare facilities must operate under names disclosed to and registered with the regulatory authority. The PMC and provincial healthcare regulatory bodies maintain records of licensed facilities, but these are regulatory records, not intellectual property registrations. A facility that is registered with the PMC under a specific name does not thereby acquire trademark rights in that name. Both regulatory registration and trademark registration are necessary.
The Drug Regulatory Authority of Pakistan regulates pharmaceutical products, including their names and branding. Drug product registration at DRAP involves approval of a specific product name for a specific manufacturer. The DRAP registration does not provide trademark protection for the product name. A drug product whose name is registered at DRAP can be protected by trademark registration in Class 5 as a separate matter. DRAP registration and IPO Pakistan trademark registration serve entirely different purposes and both are necessary for pharmaceutical brand protection.
| 💡 Pro tip |
| For healthcare brands dealing with both PMC/DRAP and IPO Pakistan, build both regulatory and trademark filing timelines into the same project plan. The regulatory registration gives you the right to operate. The trademark registration gives you the right to protect the name under which you operate. Neither substitutes for the other. A healthcare brand with PMC registration but no trademark registration is in exactly the same position as a fintech company with an SBP licence but no trademark registration: legally operating but commercially unprotected. |
Diagnostic Laboratory Brands: Specific Considerations
Diagnostic laboratory brands occupy a particularly interesting position in the healthcare brand protection landscape. Chughtai Lab, Essa Lab, and similar branded diagnostic chains have built nationally recognised brands that command significant consumer trust and premium positioning in a market where laboratory quality and accuracy directly affect patient health outcomes.
The core trademark classes for diagnostic laboratory brands are Class 44 for diagnostic testing services and Class 9 for any digital health applications through which patients access their results or book appointments. Laboratory brands that also retail health products or supplements should add Class 5. Chains that operate in multiple provinces and are expanding nationally should ensure their trademark registration adequately covers the full geographic scope of their intended operations.
Impersonation of diagnostic laboratory brands is a documented and serious problem in Pakistan. Fake laboratories operating under names confusingly similar to trusted diagnostic chains have been identified in multiple cities, with the potential to issue fabricated test results that could affect patient treatment decisions. From a trademark perspective, a diagnostic laboratory chain that has registered its brand at IPO Pakistan has the legal foundation to challenge these impersonation operations through trademark enforcement proceedings and through the relevant regulatory authorities simultaneously.
The dual track of trademark enforcement and regulatory reporting, where impersonation of a clinical brand can be reported both as trademark infringement to IPO Pakistan and as an unregistered facility to provincial healthcare regulatory authorities, is available only where the brand’s trademark is registered. Without the trademark registration, the regulatory reporting is still possible, but the trademark-based enforcement pathway, which can provide faster commercial relief through injunctions, is not.
Pharmacy Chain Brands: Specific Considerations
Branded pharmacy chains are one of the fastest-growing segments of Pakistan’s retail healthcare sector. The transition from individual pharmacies trading under generic names to consolidated national chains under distinctive brand names has created significant trademark considerations for this segment.
A pharmacy chain brand requires trademark registration in Class 5 for the pharmaceutical and health products retailed under the brand name, and in Class 44 for the pharmacy and dispensing services provided. For pharmacy chains that have expanded into health diagnostics, wellness services, or digital health through their brand, additional classes may be relevant.
Counterfeit pharmaceutical retailing under a trusted pharmacy chain’s name is both a trademark infringement and a serious public health risk. A patient who purchases medicines from a fake outlet impersonating a trusted pharmacy chain may be receiving substandard, falsified, or incorrectly labelled products. Healthcare regulatory enforcement and trademark enforcement are both relevant responses to this problem, and both are most effectively deployed by brands that hold current trademark registrations.
Telemedicine and Digital Health Platforms: Specific Considerations
Pakistan’s telemedicine and digital health sector has grown significantly. Telemedicine platforms, health information apps, digital pharmacy services, and electronic health record systems have created new brand categories in the healthcare space.
For telemedicine brands, the critical trademark classes are Class 44 for the medical consultation services delivered through the platform and Class 9 for the mobile application or software through which those services are accessed. Class 38 may be relevant if the telemedicine service operates on telecommunications infrastructure. Class 35 is relevant if the platform also provides healthcare administration or management services to hospitals and clinics.
Digital health brands face specific brand protection challenges related to the speed of brand development in the technology sector, the ease of replicating app interfaces and brand identities, and the patient trust implications of an impersonation digital health platform capturing patient data or providing inaccurate health information. The fraudulent app impersonation risk documented for fintech brands in the preceding blog applies equally, and in some respects more acutely, to digital health platforms where the stakes of consumer deception are patient safety rather than financial loss.
Healthcare Franchise Models: Quality Control in Trademark Licensing
Branded specialist clinic chains, whether in dermatology, dental care, physiotherapy, ophthalmology, or any other specialty, increasingly operate under franchise or licence models where a central brand is deployed across multiple clinic locations that may be independently owned or operated under standardised protocols.
As discussed in the trademark licensing and franchising guide in this series, trademark licensing without proper documentation creates risks for both the brand owner and the franchisee or licensee. In healthcare, these risks are compounded by the patient safety dimension: a franchise clinic operating under a healthcare brand’s name that provides substandard care damages both the brand’s reputation and patient health outcomes.
Healthcare franchise licence agreements need to address not only the standard trademark licensing provisions of scope, territory, duration, and termination, but also the specific clinical quality standards that any franchise location must meet to be permitted to operate under the brand name. The brand owner’s right to inspect, audit, and if necessary terminate the licence based on clinical quality failures is an essential provision in any healthcare franchise arrangement.
| 💡 The quality control imperative in healthcare licensing |
| The quality control provision in a healthcare trademark licence is not merely a legal formality. It is the mechanism through which the brand owner exercises the clinical oversight that protects both the patient and the brand. A healthcare brand that licences its name to franchise locations without robust quality control provisions is not just creating legal vulnerability. It is creating patient safety risk. The two are inseparable in the healthcare context. |
| ⚠ Real-world example |
| A well-established Pakistani diagnostic laboratory chain with a registered trademark in Class 44 discovered that a facility in a major city was operating under a name that was a minor spelling variation of the chain’s registered brand name, using a similar colour scheme and signage design, and advertising itself as a branch of the established chain. The diagnostic chain filed a trademark infringement complaint based on its Class 44 registration, simultaneously reporting the unregistered facility to the provincial healthcare regulatory authority. The court granted interim relief within three weeks, ordering the impersonation facility to cease operating under the confusingly similar name. The provincial health regulatory authority conducted an inspection of the facility, which revealed additional regulatory non-compliance issues beyond the naming matter. The dual enforcement, through both trademark proceedings and healthcare regulation, was more effective than either would have been alone. The trademark registration was the foundation of the legal enforcement track that enabled the injunction. The regulatory track addressed the patient safety dimension independently. |
| ⚠ Real-world example |
| A branded dermatology clinic chain with registered trademarks in Class 44 and Class 5 had licensed its brand to a franchise clinic in a city where it did not directly operate. The franchise licence agreement included quality control provisions requiring specified clinical standards, qualified dermatologists, and periodic inspection. When patient complaints reached the brand’s management, the quality assurance team conducted an unannounced inspection that revealed the franchise location was operating with inadequately qualified clinical staff and was not following the brand’s specified treatment protocols. Because the franchise licence agreement included explicit quality control provisions and termination rights, the brand terminated the franchise licence immediately based on the clinical standard breaches. The franchise location was required to cease using the brand name within fourteen days and return all branded materials. The patient complaints had already begun appearing on social media and healthcare rating platforms. The brand addressed this by publicly announcing the termination of the franchise relationship and the specific grounds for termination. The outcome was made possible by the combination of a registered trademark and a well-drafted franchise agreement with specific quality control provisions and clear termination rights. Without either element, the brand would have had significantly more limited tools to address the clinical standard breach. |
Step-by-Step: Building Trademark Protection for a Pakistani Healthcare Brand
Step 1: Identify All Commercial Brand Elements Across the Healthcare Operation
A healthcare brand is rarely a single entity using a single name. A hospital may operate specialist outpatient clinics, a diagnostic laboratory, a pharmacy, a training centre, and a digital health platform, all under variations of the same brand name or under sub-brand names. Each of these operational entities has distinct trademark considerations. Identify all names, logos, sub-brand names, and commercial identifiers used across the full healthcare operation before making filing decisions.
Step 2: Search IPO Pakistan and Healthcare Regulatory Databases
Conduct a comprehensive trademark search at IPO Pakistan in Classes 44, 5, 9, and other relevant classes. Also research the Pakistan Medical Commission’s facility records and provincial healthcare regulatory databases, where available, to understand the regulatory naming landscape in the relevant service area. A healthcare brand name that is already in use by a licensed facility in the same region may create not only trademark complications but regulatory and patient safety concerns.
Step 3: File in All Relevant Classes Simultaneously
File trademark applications in all relevant Nice Classes simultaneously, not sequentially. A hospital that files in Class 44 but not Class 5 or Class 9 has left pharmacy and digital health elements unprotected. A diagnostic chain that files in Class 44 but not Class 9 has left its patient-facing digital platform unprotected. The cost of filing across multiple classes simultaneously is modest. The cost of remediation when a gap is exploited is not.
Step 4: Implement Healthcare-Specific Quality Control in All Franchise Agreements
For any healthcare brand that operates through franchised or licensed clinical locations, implement a written franchise or licence agreement with explicit quality control provisions, clinical standard requirements, right of inspection, and clear termination rights for clinical standard breaches. Document the clinical standards that each franchise location is required to meet and maintain records of inspections and compliance assessments. The trademark licence agreement and the clinical quality framework should be developed together, not sequentially.
Step 5: Register with Healthcare Rating Platforms and Digital Directories
Many Pakistani healthcare consumers find clinical services through digital directories, health rating platforms, and social media. Register official profiles on all major platforms where patients search for healthcare services, and monitor these platforms for impersonation profiles or fraudulent listings using the healthcare brand’s name. Trademark registration provides the foundation for enforcement against impersonation on these platforms.
Step 6: Build Regulatory and Trademark Monitoring in Parallel
Monitor both IPO Pakistan’s trademark publications for potentially conflicting new applications in Classes 44, 5, and 9, and relevant healthcare regulatory announcements for new facility registrations in the brand’s service areas. A new facility registration under a similar name in a healthcare regulatory database may indicate a potential impersonation situation that warrants both trademark and regulatory response.
Common Mistakes Pakistani Healthcare Brands Make with Trademarks
Relying on Institutional Reputation Instead of Trademark Registration
Established Pakistani healthcare institutions sometimes operate under the assumption that their long-standing reputation and community recognition provide sufficient brand protection without formal trademark registration. This is incorrect. A long-standing reputation provides the foundation for a passing-off claim and may support a well-known mark argument, but it does not provide the statutory enforcement rights of a registered trademark. An institution that has operated for fifty years under a trusted name without registering that name as a trademark at IPO Pakistan has fifty years of brand equity in a name that anyone can register tomorrow.
Filing Only in Class 44 and Ignoring Pharmaceutical and Digital Classes
Many healthcare brands file trademark applications in Class 44 for medical services but neglect Class 5 for pharmaceutical and health products and Class 9 for digital health applications. As the healthcare sector integrates pharmacy retail, diagnostic testing, and digital health delivery into single brand offerings, this class gap creates protection vulnerabilities in exactly the areas where the most rapid commercial development is occurring.
Not Documenting Clinical Quality Standards in Franchise Agreements
Healthcare franchise models that expand under a well-known clinical brand without detailed, written clinical quality standards in the franchise agreement are creating both patient safety risks and brand reputation risks that trademark registration alone cannot address. The trademark registration protects the brand name. The franchise agreement with robust quality control provisions protects the clinical standard that the brand name represents. Both are needed.
Treating Regulatory Registration as Trademark Protection
The most common misunderstanding in the healthcare brand protection context is the belief that regulatory registration at the PMC, provincial health authorities, or DRAP provides some form of brand name protection. It does not. Regulatory registration and trademark registration serve entirely different purposes and both are necessary.
Frequently Asked Questions
Can a Not-for-Profit Hospital Register Its Name as a Trademark?
Yes. Trademark registration at IPO Pakistan is available to any legal entity, including not-for-profit organisations, trusts, and charitable institutions. A not-for-profit hospital or medical institution can register its brand name and logo as trademarks in the same way as a for-profit entity. The registration protects the institutional brand from impersonation and misuse regardless of the institution’s commercial status.
Does the PMC or Provincial Health Authority Registration Protect the Hospital’s Name from Being Used by Another Facility?
No. PMC and provincial health authority registration records the facility as a licensed healthcare institution. It does not create trademark rights in the facility’s name. Another party could register the same or a similar name as a trademark at IPO Pakistan independently of the healthcare regulatory databases. Trademark registration at IPO Pakistan is a separate process that provides this form of brand name protection.
Can a Telemedicine Platform Register Its Name in Class 44 Even Though It Does Not Provide Direct In-Person Clinical Care?
Yes. Class 44 covers medical services broadly, including digital and online medical services. A telemedicine platform that provides medical consultations through digital channels is providing a medical service within the scope of Class 44. The specific goods and services description within the Class 44 application should accurately reflect the digital delivery model of the services, for example including online medical consultation services and telemedicine services in the description.
How Does Trademark Registration Help Against Fake Diagnostic Laboratories?
A registered trademark in Class 44 for diagnostic testing services gives the trademark holder the legal basis to initiate trademark infringement proceedings against a facility using the same or a confusingly similar name. This provides access to civil remedies including injunctions, which can order the impersonation facility to immediately cease using the confusingly similar name, and damages. The registered trademark is also the foundation for regulatory enforcement referrals and for platform-based enforcement if the impersonation facility has an online presence.
Should a Healthcare Brand Register Its Tagline or Visual Identity Separately from the Institution Name?
Where a tagline or visual identity element has acquired significant commercial recognition, separate trademark registration may be warranted. The institution name registered as a word mark and the logo registered as a device mark are the two most commonly registered elements for healthcare brands. A highly distinctive tagline that is consistently used commercially and has become a brand identifier may also warrant separate registration.
Final Thoughts
Healthcare brand protection in Pakistan is not just a commercial matter. It is a patient safety matter. When a diagnostic laboratory is impersonated, patients are at risk of receiving fabricated test results. When a pharmacy chain’s name is used by a fraudulent operator, patients are at risk of receiving substandard medicines. When a clinical franchise expands without quality control standards enforced through properly documented licence agreements, patients at franchise locations are at risk of receiving care that does not meet the standards associated with the brand they chose.
The tools to address all of these risks exist. Trademark registration in Classes 44, 5, and 9 provides the legal foundation for enforcement. Well-documented franchise agreements with clinical quality control provisions provide the contractual framework for brand standard enforcement. Active monitoring of impersonation and fraudulent clinical operations provides early warning. And dual enforcement through trademark proceedings and healthcare regulatory bodies provides the most comprehensive response when impersonation is identified.
Pakistan’s healthcare brands, whether century-old teaching hospitals or newly launched telemedicine platforms, deserve the same legal protection as any other commercially valuable brand. The stakes of failing to provide that protection are, in healthcare, simply higher than anywhere else.
| Get Started with TM |
| TM helps Pakistani healthcare providers, hospital brands, diagnostic chains, pharmacy networks, and digital health companies register and protect their trademarks at IPO Pakistan and in key international markets. Visit: tm.com.pk/contact Email: contact@tm.com.pk Phone: 03-111-456-456 |